Skip to main content
. 2013 Sep 14;19(34):5738–5749. doi: 10.3748/wjg.v19.i34.5738

Figure 7.

Figure 7

Individual and pooled relative risk (A) and heterogeneity indicators (B) for the outcome of “endoscopic remission” in the studies considering herbal medicines comparing to placebo therapy in inflammatory bowel disease (ulcerative colitis) patients.